Radiosynoviorthesis. Clinical and preclinical dosimetry

Accurate calculation of internal dose estimates in the Radiosynoviorthesis treatment requires several steps of analysis. The use of animal models (rabbits) to predict human kinetics and dosimetry is an essential first step in the evaluation of new radiocolloids, but involves many uncertainties. There is no gold standard method for extrapolating animal data to humans. Nonetheless, human dose estimates based on animal data are considered to be reasonable approximations to be used for proceeding with dose estimates based on human data, which are ultimately used to assess the safety and efficacy evaluations of radiopharmaceuticals, and continues to be an important element in the radiopharmaceutical approval process. The obtained absorbed dose profiles versus synovial tissue, bone and articular cartilage depth will permit the specialist to prescribe the adequate dose of radionuclide to treat rheumatoid arthritis in medium and large joints without expose the healthy structures of the synovial joint to an excessive and unnecessary irradiation risk, eliminating the fixed dose and fixed radionuclides for each joints (Author)